General Information of the Compound
Compound ID
CP0455640
Compound Name
4-Pyridazin-3-yl-piperazine-1-carboxylic acid (4-trifluoromethoxy-phenyl)-amide
    Show/Hide
Structure
Formula
C16H16F3N5O2
Molecular Weight
367.331
Canonical SMILES
FC(F)(F)Oc1ccc(NC(=O)N2CCN(CC2)c2cccnn2)cc1
    Show/Hide
InChI
InChI=1S/C16H16F3N5O2/c17-16(18,19)26-13-5-3-12(4-6-13)21-15(25)24-10-8-23(9-11-24)14-2-1-7-20-22-14/h1-7H,8-11H2,(H,21,25)
    Show/Hide
InChIKey
JKKHWYAGQCYXEK-UHFFFAOYSA-N
Physicochemical Property
logP
2.7293
Rotatable Bonds
3
Heavy Atom Count
26
Polar Areas
70.59
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44396094
ChEMBL ID
CHEMBL188171
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS